Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Basic Res Cardiol. 2015 Mar 25;110(3):21. doi: 10.1007/s00395-015-0477-6

Fig. 2.

Fig. 2

AT2R antagonist blocks Ang II-stimulation of nNOS protein expression and activity in LV myocytes. a Isolated LV myocytes were pre-incubated with AT2R antagonist, PD123319 (1 μM). PD123319 blocked Ang II-stimulation of nNOS protein expression. b PD123319 prevented Ang II-induced increase in NO production. c AT2R agonist, CGP42112A (1 μM, 3 h), significantly increased nNOS protein expression